Notably, TLR-dependent tumor cell-killing was inhibited by SREC-1 knockdown in DCs, suggesting a crucial role of SREC-1 in HSP70-mediated tumor immunity [113,115]. The gene discussed is SCARF1; the disease is neoplasm.